Postherpetic neuralgia in Europe: The scale of the problem and outlook for the future

Journal of Clinical Gerontology and Geriatrics

Volumn 4, Issue 4, 2013, Pages 102-108

  Mick, Gérard ^a   Hans, Guy ^b  

^a HÔPITAL NEUROLOGIQUE   (France)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Herpes zoster; Herpes zoster treatment; Herpes zoster vaccine; Postherpetic pain; Varicella zoster virus

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; ANTIVIRUS AGENT; CAPSAICIN; CORTICOSTEROID; FAMCICLOVIR; GABAPENTIN; LIDOCAINE; OPIATE; PREGABALIN; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR; VARICELLA ZOSTER VACCINE;

AGE; ATAXIA; CLINICAL FEATURE; COGNITIVE DEFECT; CONSTIPATION; DISEASE DURATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EUROPE; HERPES ZOSTER; HUMAN; IMMUNOGENICITY; INCIDENCE; INJECTION SITE REACTION; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SKIN DISCOMFORT; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS REACTIVATION; XEROSTOMIA;

EID: 84888127488     PISSN: 22108335     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcgg.2013.03.001     Document Type: Review

References (81)

1. A. Arvin Aging, immunity, and the varicella-zoster virus N Engl J Med 352 2005 2266 2267
2. R.W. Johnson, G. Wasner, P. Saddier, and R. Baron Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient Drugs Aging 25 2008 991 1006
3. C. Chidiac, J. Bruxelle, J.-P. Daures, T. Hoang-Xuan, P. Morel, and A. Leplège Characteristics of patients with herpes zoster on presentation to practitioners in France Clin Infect Dis 33 2001 62 69
4. R.W. Johnson, G. Wasner, P. Saddier, and R. Baron Postherpetic neuralgia: epidemiology, pathophysiology and management Expert Rev Neurother 7 2007 1581 1595
5. F.T. Scott, R.W. Johnson, M. Leedham-Green, E. Davies, W.J. Edmunds, and J. Breuer The burden of herpes zoster: a prospective population based study Vaccine 24 2006 1308 1314
6. A. Gauthier, J. Breuer, D. Carrington, M. Martin, and V. Remy Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom Epidemiol Infect 137 2009 38 47
7. R.H. Dworkin, and R.K. Portenoy Pain and its persistence in herpes zoster Pain 67 1996 241 251
8. J. Bruxelle Prospective epidemiologic study of painful and neurologic sequelae induced by herpes zoster in patients treated early with oral acyclovir Neurology 45 12 Suppl 8 1995 S78 S79
9. F.T. Scott, M.E. Leedham-Green, W.Y. Barrett-Muir, K. Hawrami, W.J. Gallagher, and R. Johnson A study of shingles and the development of postherpetic neuralgia in East London J Med Virol 70 Suppl. 1 2003 S24 S30
10. D. Bouhassira, O. Chassany, J. Gaillat, T. Hanslik, O. Launay, and C. Mann Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice Pain 153 2012 342 349
11. R.B. Arani, S.-J. Soong, H.L. Weiss, M.J. Wood, P.A. Fiddian, and J.W. Gnann Phase specific analysis of herpes zoster associated pain data: a new statistical approach Stat Med 20 2001 2429 2439
12. R.A. Desmond, H.L. Weiss, R.B. Arani, S.J. Soong, M.J. Wood, and P.A. Fiddian Clinical applications for change-point analysis of herpes zoster pain J Pain Symptom Manage 23 2002 510 516
13. B.F. Jung, R.W. Johnson, D.R. Griffin, and R.H. Dworkin Risk factors for postherpetic neuralgia in patients with herpes zoster Neurology 62 2004 1545 1551
14. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms H. Merskey, and N. Bogduk Task force on taxonomy of the International Association for the Study of Pain 2nd ed. 1994 IASP Press Seattle 39 43
15. R.W. Johnson Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes 14 Suppl. 2 2007 30 34
16. P.M. Coplan, K. Schmader, A. Nikas, I.S. Chan, P. Choo, and M.J. Levin Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the Brief Pain Inventory J Pain 5 2004 344 356
17. M.N. Oxman, M.J. Levin, G.R. Johnson, K.E. Schmader, S.E. Straus, and L.D. Gelb A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2005 2271 2284
18. H.G. Thyregod, M.C. Rowbotham, M. Peters, J. Possehn, M. Berro, and K.L. Petersen Natural history of pain following herpes zoster Pain 128 2007 148 156
19. R.H. Dworkin Inadequate evidence for a revised definition of postherpetic neuralgia (PHN) Pain 128 2007 189 192
20. Groupe d'Experts Douleurs Neuropathiques Thoughts on the definition of postherpetic pain: the time criterion adds nothing Rev Neurol (Paris) 160 2004 721 725 [in French]
21. D. Bouhassira, N. Attal, J. Fermanian, H. Alchaar, M. Gautron, and E. Masquelier Development and validation of the Neuropathic Pain Symptom Inventory Pain 108 2004 248 257
22. M. Brisson, W.J. Edmunds, B. Law, N.J. Gay, R. Walld, and M. Brownell Epidemiology of varicella zoster virus infection in Canada and the United Kingdom Epidemiol Infect 127 2001 305 314
23. M.W. Ragozzino, L.J. Melton 3rd, L.T. Kurland, C.P. Chu, and H.O. Perry Population-based study of herpes zoster and its sequelae Medicine (Baltimore) 61 1982 310 316
24. R.E. Hope-Simpson Postherpetic neuralgia J R Coll Gen Pract 25 1975 571 575
25. E. Miller, R. Marshall, and J. Vurdien Epidemiology, outcome and control of varicella-zoster infection Rev Med Microbiol 4 1993 222 230
26. K. Schmader Herpes zoster in older adults Clin Infect Dis 32 2001 1481 1486
27. A. Volpi, G. Gross, J. Hercogova, and R.W. Johnson Current management of herpes zoster: the European view Am J Clin Dermatol 6 2005 317 325
28. R.W. Johnson Patient awareness of herpes zoster: the Global Herpes Zoster Survey-a preliminary report Herpes 13 Suppl. 1 2006 40A 41A
29. S. Czernichow, A. Dupuy, A. Flahault, and O. Chosidow Herpes zoster: incidence study among 'sentinel' general practitioners Ann Dermatol Venereol 128 2001 497 501 [in French]
30. W. Opstelten, J.W. Mauritz, N.J. de Wit, A.J. van Wijck, W.A. Stalman, and G.A. van Essen Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database Fam Pract 19 2002 471 475
31. M. Brisson, and W.J. Edmunds Epidemiology of varicella-zoster virus in England and Wales J Med Virol 70 Suppl. 1 2003 S9 14
32. H. de Melker, G. Berbers, S. Hahné, H. Rümke, S. van den Hof, and A. de Wit The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination Vaccine 24 2006 3946 3952
33. V. Di Legami, M.M. Gianino, M. Ceofi degli Atti, M. Massari, A. Migliardi, and G.S. Tomba Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination Vaccine 25 2007 7598 7604
34. R.G. Kost, and S.E. Straus Postherpetic neuralgia-pathogenesis, treatment, and prevention N Engl J Med 335 1996 32 42
35. M.J. Wood, R. Kay, R.H. Dworkin, S.J. Soong, and R.J. Whitley Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials Clin Infect Dis 22 1996 341 347
36. G. Mick, J.-L. Gallais, F. Simon, S. Pinchinat, K. Bloch, and M. Beillat Burden of herpes zoster and postherpetic neuralgia: incidence, proportion, and associated costs in the French population aged 50 or over Rev Epidemiol Sante Publique 58 2010 393 401
37. S. Helgason, G. Petursson, S. Gudmundsson, and J.A. Sigurdsson Prevalence of postherpetic neuralgia after a single episode of herpes zoster: prospective study with long term follow up Br Med J 321 2000 794 796
38. A. Cebrian, J. Duiez-Domingo, and M. San-Martin Burden of herpes zoster in persons > 50 years of age in primary care in Spain J Nutr Health Aging 12 2008 566
39. P.G. Coen, F. Scott, M. Leedham-Green, T. Nia, A. Jamil, and R.W. Johnson Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice? Eur J Pain 10 2006 695 700
40. A.M. Cebrian-Cuenca, J. Diez-Domingo, M. San-Martin-Rodriguez, J. Puig-Barberá, and J. Navarro-Pérez Herpes Zoster Research Group of the Valencian Community. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian Community of Spain BMC Infect Dis 11 2011 302
41. J. Katz, M.P. McDermott, E.M. Cooper, R.R. Walther, E.W. Sweeney, and R.H. Dworkin Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster J Pain 6 2005 782 790
42. A. Volpi, A. Gatti, F. Pica, S. Bellino, L.T. Marsella, and A.F. Sabato Clinical and psychosocial correlates of post-herpetic neuralgia J Med Virol 80 2008 1646 1652
43. P.W. Choo, K. Galil, J.G. Donahue, A.M. Walker, D. Spiegelman, and R. Platt Risk factors for postherpetic neuralgia Arch Intern Med 157 1997 1217 1224
44. K. Schmader, J.W. Gnann Jr., and C.P. Watson The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine J Infect Dis 197 Suppl. 2 2008 S207 S215
45. W. Opstelten, N.P. Zuithoff, G.A. van Essen, A.M. van Loon, A.J. van Wijck, and C.J. Kalkman Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study Pain 132 Suppl. 2 2007 S52 S59
46. M. Drolet, M. Brisson, K. Schmader, M. Levin, R. Johnson, and M. Oxman Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study J Pain 11 2010 1211 1221
47. W. Opstelten, G.A. van Essen, F. Schellevis, T.J. Verheij, and K.G. Moons Gender as an independent risk factor for herpes zoster: a population-based prospective study Ann Epidemiol 16 2006 692 695
48. D. Bowsher The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population Eur J Pain 3 1999 335 342
49. R.H. Dworkin, E.M. Nagasako, R.W. Johnson, and D.R. Griffin Acute pain in herpes zoster: the famciclovir database project Pain 94 2001 113 119
50. G. Pickering, and A. Leplege Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly Pain Pract 11 2011 397 402
51. T. Weinke, A. Edte, S. Schmitt, and K. Lukas Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey Z Gesundh Wiss 18 2010 367 374
52. R.W. Johnson, D. Bouhassira, G. Kassianos, A. Leplège, K.E. Schmader, and T. Weinke The impact of herpes zoster and post-herpetic neuralgia on quality-of-life BMC Med 8 2010 37
53. K. Hempenstall, T.J. Nurmikko, R.W. Johnson, R.P. A'Hern, and A.S. Rice Analgesic therapy in postherpetic neuralgia: a quantitative systematic review PLoS Med 2 2005 e164
54. R. Baron, V. Mayoral, G. Leijon, A. Binder, I. Steigerwald, and M. Serpell Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy Curr Med Res Opin 25 2009 1677 1687
55. Y. Han, J. Zhang, N. Chen, L. He, M. Zhou, and C. Zhu Corticosteroids for preventing postherapetic neuralgia Cochrane Database of Systematic Reviews Issue 13 2013 Art. No.: CD005582. http://dx.doi.org/10.1002/14651858. CD005582.pub4.
56. N. Attal, G. Cruccu, M. Haanpää, P. Hansson, T.S. Jensen, and T. Nurmikko EFNS guidelines on pharmacological treatment of neuropathic pain Eur J Neurol 13 2006 1153 1169
57. C.E. Argoff, N. Katz, and M. Backonja Treatment of postherpetic neuralgia: a review of therapeutic options J Pain Symptom Manage 28 2004 396 411
58. R.H. Dworkin, A.B. O'Connor, M. Backonja, J.T. Farrar, N.B. Finnerup, and T.S. Jensen Pharmacologic management of neuropathic pain: evidence-based recommendations Pain 132 2007 237 251
59. A. Binder, and R. Baron Postherpetic neuralgia-fighting pain with fire Lancet Neurol 7 2008 1077 1078
60. M.W. Douglas, R.W. Johnson, and A.L. Cunningham Tolerability of treatments for postherpetic neuralgia Drug Safety 27 2004 1217 1233
61. R. Johnson, J. McElhaney, B. Pedalino, and M. Levin Prevention of herpes zoster and its painful and debilitating complications Int J Infect Dis 11 Suppl. 2 2007 S43 S48
62. British Society for the Study of Infection (BSSI) Guidelines for the management of shingles. Report of a working group of the British Society for the Study of Infection (BSSI) J Infect 30 1995 193 200
63. G. Gross, H. Schöfer, S. Wassilew, K. Friese, A. Timm, and R. Guthoff Herpes zoster guidelines of the German Dermatology Society (DDG) J Clin Virol 26 2003 277 289
64. J.W. Gnann Jr. Antiviral therapy for herpes zoster Herpes 13 Suppl. 1 2006 16A 20A
65. W. Opstelten, G.A. van Essen, K.G. Moons, A.J. van Wijck, F.G. Schellevis, and C.J. Kalkman Do herpes zoster patients receive antivirals? A Dutch National Survey in General Practice Fam Pract 22 2005 523 528
66. B.S. Alper, and P.R. Lewis Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? J Fam Pract 49 2000 255 264
67. Q. Li, N. Chen, J. Yang, M. Zhou, D. Zhou, and Q. Zhang Antiviral treatment for preventing postherpetic neuralgia Cochrane Database Syst Rev 2 2009 CD006866
68. M.N. Oxman, M.J. Levin, and Shingles Prevention Study Group Vaccination against herpes zoster and postherpetic neuralgia J Infect Dis 197 Suppl. 2 2008 S228 S236
69. K. Schmader, M.N. Oxman, M. Levin, G. Johnson, J.H. Zhang, and R. Betts Persistence of the efficacy of zoster vaccine in the Shingles Prevention Study and the Short-term Persistence Substudy Clin Infect Dis 55 2012 1320 1328
70. ClinicalTrials.gov. 2011. Trial ID: NCT00534248: http://clinicaltrials. gov/ct2/results?term=nct00534248 [accessed 30.12.11].
71. N. Chen, Q. Li, Y. Zhang, M. Zhou, D. Zhou, and L. He Vaccination for preventing postherpetic neuralgia Cochrane Database Syst Rev 3 2011 CD007795
72. M. Brisson, J.M. Pellissier, and M.J. Levin Cost-effectiveness of zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia Clin Infect Dis 45 2007 1527 1529
73. L. Moore, V. Remy, M. Martin, M. Beillat, and A. McGuire A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK Cost Eff Resour Alloc 8 2010 7
74. L. Annemans, X. Bresse, C. Gobbo, and M. Papageorgiou Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium J Med Econ 13 2010 537 551
75. A.J. van Hoek, N. Gay, A. Melegaro, W. Opstelten, and W.J. Edmunds Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales Vaccine 27 2009 1454 1467
76. A. van Lier, A.J. van Hoek, W. Opstelten, H.J. Boot, and H.E. de Melker Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in The Netherlands BMC Health Serv Res 10 2010 237
77. T.D. Szucs, R.W. Kressig, M. Papageorgiou, W. Kempf, J.P. Michel, and A. Fendl Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland Hum Vaccin 7 2011 749 756
78. J. Leung, R. Harpaz, N.A. Molinari, A. Jumaan, and F. Zhou Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination Clin Infect Dis 52 2011 332 340
79. A. Ali, H. Nguyen, A. Jumaan, J. Zhang, P. Spradling, and Seward Decline in annual incidence of varicella - selected states, 1990-2001 MMWR 52 2003 884 885
80. P. Tanuseputro, B. Zagorski, K.J. Chan, and J.C. Kwong Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program Vaccine 29 2011 8580 8584
81. A.J. van Hoek, A. Melegaro, E. Zagheni, W.J. Edmunds, and N. Gay Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England Vaccine 29 2011 2411 2420